Federal Register Notice: FDA is announcing the availability of grant funds to support FDA’s Office of Orphan Products Development grant program. The goal of the program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the proposed product will be superior to the existing therapy. To view this notice, click here.
